BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32572849)

  • 1. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
    Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
    Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
    Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
    BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
    Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
    Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
    Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
    Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
    Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).
    Lurvink RJ; Rovers KP; Wassenaar ECE; Bakkers C; Burger JWA; Creemers GM; Los M; Mols F; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    Surg Endosc; 2022 Jun; 36(6):4486-4498. PubMed ID: 34757489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
    Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
    Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
    Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
    Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy.
    Giger-Pabst U; Bucur P; Roger S; Falkenstein TA; Tabchouri N; Le Pape A; Lerondel S; Demtröder C; Salamé E; Ouaissi M
    Ann Surg Oncol; 2019 Dec; 26(13):4445-4451. PubMed ID: 31399820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
    BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
    Taibi A; Sgarbura O; Hübner M; Bardet SM; Alyami M; Bakrin N; Durand Fontanier S; Eveno C; Gagniere J; Pache B; Pocard M; Quenet F; Teixeira Farinha H; Thibaudeau E; Dumont F; Glehen O
    Ann Surg Oncol; 2022 Aug; 29(8):5243-5251. PubMed ID: 35318519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
    Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
    Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
    Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application.
    Reymond M; Demtroeder C; Solass W; Winnekendonk G; Tempfer C
    Pleura Peritoneum; 2016 Jun; 1(2):109-116. PubMed ID: 30911614
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
    van de Vlasakker VCJ; Lurvink RJ; Wassenaar EC; Rauwerdink P; Bakkers C; Rovers KP; Bonhof CS; Burger JWA; Wiezer MJ; Boerma D; Nienhuijs SW; Mols F; de Hingh IHJT
    Sci Rep; 2023 Nov; 13(1):20458. PubMed ID: 37993560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
    Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
    Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
    Dumont F; Passot C; Raoul JL; Kepenekian V; Lelièvre B; Boisdron-Celle M; Hiret S; Senellart H; Pein F; Blanc-Lapierre A; Raimbourg J; Thibaudeau E; Glehen O;
    Eur J Cancer; 2020 Nov; 140():37-44. PubMed ID: 33039812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
    Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
    Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflection: Systemic Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy with Oxaliplatin in Patients with Colorectal Peritoneal Metastases.
    Lurvink RJ; Rovers KP; de Hingh IHJT; Deenen MJ
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):799-800. PubMed ID: 32602062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.